Loading...
ALXP
ALDMS
Market cap28mUSD
Oct 28, Last price  
0.95EUR
1D
0.85%
1Q
-11.40%
Jan 2017
-53.07%
Name

Diagnostic Medical Systems SA

Chart & performance

D1W1MN
ALXP:ALDMS chart
P/E
—
P/S
0.51
EPS
—
Vol. 1Y
31.44%
Shs. 5Y
—
Rev. 5Y
3.92%
Div Yld LY
—
Div Yld TTM
—
Revenues
50m
50,000,000
Net income
-167k
-167,000
CFO
-254k
-254,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Diagnostic Medical Systems S.A. (DMS), a French company founded in 1979 and headquartered in Mauguio, is a key player in the medical imaging industry. DMS offers an extensive portfolio of diagnostic solutions, including radiography and fluoroscopy systems, upgrade kits, mammography equipment, specialized rooms for chest and bone analysis, mobile devices, bone densitometry tools, 3D reconstruction capabilities, portable C-arm X-ray machines, and posturology solutions. The company also distributes its products internationally.

Related entities

Subsidiaries

Key people

Julie Moreau
Chief Human Resource Officer
Jean-Philippe Dross
Director of Customer Service
Laure Landucci
Responsible for Regulatory Affairs & Quality
Michael Sifre
Director of Production
David Terreehorst
Purchasing Manager
Richard Voisinne
Supply Chain Director
Samuel Sancerni
Deputy Chief Executive Officer, Director · since 2017
Simonyi See-Nuan
Independent Director · since 2012
IPO date
Jan 01, 1998
Employees
128
Domiciled in
FR
Incorporated in
FR
Headquarters & legal address
9 AVENUE DU CANAL PHILIPPE LAMOUR
GALLARGUES-LE-MONTUEUX 30660
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FY
2025‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT